These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1129265)

  • 21. Multiple-dose pharmacokinetics and in vitro antimalarial activity of dapsone plus pyrimethamine (Maloprim) in man.
    Edstein MD; Rieckmann KH; Veenendaal JR
    Br J Clin Pharmacol; 1990 Aug; 30(2):259-65. PubMed ID: 2206787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of dapsone-induced methaemoglobinaemia in the rat isolated perfused liver.
    Coleman MD; Hoaksey PE; Breckenridge AM; Park BK
    J Pharm Pharmacol; 1990 May; 42(5):302-7. PubMed ID: 1976775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of acetylator phenotype of the leprosy patient on the emergence of dapsone resistant leprosy.
    Raj PP; Aschhoff M; Lilly L; Balakrishnan S
    Indian J Lepr; 1988 Jul; 60(3):400-6. PubMed ID: 3058828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dapsone-induced hematologic toxicity: comparison of the methemoglobin-forming ability of hydroxylamine metabolites of dapsone in rat and human blood.
    Vage C; Saab N; Woster PM; Svensson CK
    Toxicol Appl Pharmacol; 1994 Dec; 129(2):309-16. PubMed ID: 7992320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of cancer chemotherapy on dapsone N-acetylation in man.
    Philip PA; Harper PG; Rogers HJ
    Cancer Chemother Pharmacol; 1989; 23(6):395-6. PubMed ID: 2713961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A field trial among leprosy patients in Nigeria with depot injections of dapsone and monoacetyldapsone.
    Pieters FA; Woonink F; Zuidema J
    Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):10-20. PubMed ID: 3373080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood dapsone levels in leprosy patients treated with acedapsone.
    George J; Balakrishnan S
    Indian J Lepr; 1986; 58(3):401-6. PubMed ID: 3794408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral activated charcoal and dapsone elimination.
    Neuvonen PJ; Elonen E; Mattila MJ
    Clin Pharmacol Ther; 1980 Jun; 27(6):823-7. PubMed ID: 7379451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphic acetylation of the antibacterials, sulfamethazine and dapsone, in South Indian subjects.
    Peters JH; Gordon GR; Karat AB
    Am J Trop Med Hyg; 1975 Jul; 24(4):641-8. PubMed ID: 1155699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoacetyldapsone inhibition of dapsone N-hydroxylation by human and rat liver microsomes.
    Irshaid Y; Adedoyin A; Lotze M; Branch RA
    Drug Metab Dispos; 1994; 22(1):161-4. PubMed ID: 8149877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical pharmacokinetics of dapsone.
    Zuidema J; Hilbers-Modderman ES; Merkus FW
    Clin Pharmacokinet; 1986; 11(4):299-315. PubMed ID: 3530584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-performance liquid chromatography determination of dapsone, monoacetyldapsone, and pyrimethamine in filter paper blood spots.
    Rønn AM; Lemnge MM; Angelo HR; Bygbjerg IC
    Ther Drug Monit; 1995 Feb; 17(1):79-83. PubMed ID: 7725382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous high performance liquid chromatographic determination of dapsone and monoacetyldapsone in human plasma and urine.
    Abuirjeie MA; Irshaid YM; al-Hadidi HF; Rawashdeh NM
    J Clin Pharm Ther; 1991 Aug; 16(4):247-55. PubMed ID: 1939403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that the biotransformation of dapsone and monoacetyldapsone to their respective hydroxylamine metabolites in rat liver microsomes is mediated by cytochrome P450 2C6/2C11 and 3A1.
    Vage C; Svensson CK
    Drug Metab Dispos; 1994; 22(4):572-7. PubMed ID: 7956732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Race-linked differences in serum concentrations of dapsone, monoacetyldapsone and pyrimethamine during malaria prophylaxis.
    Cook IF; Cochrane JP; Edstein MD
    Trans R Soc Trop Med Hyg; 1986; 80(6):897-901. PubMed ID: 3299903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple-dose kinetics in healthy volunteers and in vitro antimalarial activity of proguanil plus dapsone.
    Edstein MD; Veenendaal JR; Rieckmann KH
    Chemotherapy; 1990; 36(3):169-76. PubMed ID: 2186899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acetylation of dapsone by human whole blood.
    Irshaid YM; al-Hadidi HF; Abuirjeie MA; Rawashdeh NM; Gharaibeh NS
    Int J Clin Pharmacol Ther Toxicol; 1993 Jan; 31(1):18-22. PubMed ID: 8444513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics of dapsone after oral administration to healthy volunteers.
    Pieters FA; Zuidema J
    Br J Clin Pharmacol; 1986 Oct; 22(4):491-4. PubMed ID: 3768260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of pregnenolone 16alpha-carbonitrile on the pharmacokinetics and metabolism of dapsone in rats.
    Lu M; Poloyac SM; McNamara PJ; Blouin RA
    J Pharm Pharmacol; 1999 Jul; 51(7):803-10. PubMed ID: 10467955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The methaemoglobin forming and GSH depleting effects of dapsone and monoacetyl dapsone hydroxylamines in human diabetic and non-diabetic erythrocytes in vitro.
    Coleman MD; Holden LJ
    Environ Toxicol Pharmacol; 2004 May; 17(1):55-9. PubMed ID: 21782713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.